Clinical Trial Update: Quantitative MRI for Myelofibrosis

View source ↗

Summary

A clinical trial at the University of Michigan Rogel Cancer Center is exploring quantitative MRI for myelofibrosis and is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Myelofibrosis | Status: RECRUITING